iShares MSCI France ETF vs Heron Therapeutics Inc — how do they compare? iShares MSCI France ETF trades at $47.51, while Heron Therapeutics Inc trades at $0.36 (market cap $61.47M). The key difference: iShares MSCI France ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| EWQ | HRTX | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $48.35 | $1.49 |
52-Week Low | $41.68 | $0.32 |
Market Cap | — | $61.47M |
Enterprise Value | — | $168.21M |
Signals from Pluang's Aura AI — not financial advice
EWQ, the iShares MSCI France ETF, trades at $47.505, down 0.51% on the day, with a bullish technical signal driven by moving averages. The ETF focuses on French equities, particularly industrials, and offers a dividend scheduled for June 2026. Recent news highlights ECB rate decisions and French tech investments, influencing sentiment.
The outlook for EWQ is supported by bullish technicals and positive analyst views on French stocks, but risks include ECB policy shifts and geopolitical tensions. Investors may find opportunity in Europe's cyclical recovery, though volatility from energy prices and economic data poses challenges.
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
Trailing returns across standard periods
Latest headlines on both assets
EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.
Read more on EWQ →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →